Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today’s fragmented healthcare system leaves many people unsure how to pursue treatment...
Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. ...
Karman, Circle Internet, and Hinge Health were IPO winners in 2025. Their strong growth helped drive performance, and analysts see shares going even higher.
Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared...
Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, we generated...
Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. “With healthcare costs rising dramatically, our mission to automate care delivery...
Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI Care...
Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow...
The health tech company is currently trading below its IPO price of $23 per share.
/The%20logo%20for%20Hinge%20Health%20displayed%20on%20a%20smartphone%20by%20T_%20Schneider%20%20via%20Shutterstock_com.jpg)
Hinge Health stock recently went public via an IPO. Is the health-tech company a good buy right now given its steady revenue and earnings growth profile?